UK markets close in 1 hour 57 minutes

Apyx Medical Corporation (APYX)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
1.4300+0.0300 (+2.14%)
As of 04:00PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-19,138
-18,713
-23,184
-15,172
-11,896
Depreciation & amortisation
917
692
890
903
887
Stock-based compensation
6,397
5,114
6,697
5,088
4,210
Change in working capital
-4,628
5,543
-5,217
-1,843
-10,253
Accounts receivable
1,540
-3,574
1,918
-4,901
-558
Inventory
-6,549
1,459
-5,568
-2,859
615
Accounts payable
-840
25
67
1,154
-965
Other working capital
-16,736
-5,782
-21,290
-11,172
-16,647
Other non-cash items
632
632
-
-
-
Net cash provided by operating activities
-15,536
-5,249
-20,280
-10,449
-16,066
Cash flows from investing activities
Investments in property, plant and equipment
-1,200
-533
-1,010
-723
-581
Purchases of investments
-
-
-
-
0
Sales/maturities of investments
-
-
-
-
0
Net cash used for investing activities
-1,200
6,734
-1,010
-723
-581
Cash flows from financing activities
Debt repayment
-195
-11,067
-148
-238
-369
Other financing activities
-2,959
-2,959
-
195
148
Net cash used provided by (used for) financing activities
188
32,166
217
24
-73
Net change in cash
-16,065
33,460
-20,678
-11,045
-16,897
Cash at beginning of period
30,898
10,192
30,870
41,915
58,812
Cash at end of period
14,350
43,652
10,192
30,870
41,915
Free cash flow
Operating cash flow
-15,536
-5,249
-20,280
-10,449
-16,066
Capital expenditure
-1,200
-533
-1,010
-723
-581
Free cash flow
-16,736
-5,782
-21,290
-11,172
-16,647